Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O'Toole

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Bacteriology|July 10, 1999
The chemotactic response of Vibrio anguillarum to fish intestinal mucus is mediated by a combination of multiple mucus componentsR O'Toole, S Lundberg, S A Fredriksson, et al.
Obstetrics and Gynecology|April 1, 1990
Carboplatin therapy in advanced endometrial cancerJ B Green, S Green, D S Alberts, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 15, 2017
Prevention of Tracheostomy-Related Hospital-Acquired Pressure UlcersThomas R O'Toole, Natalie Jacobs, Brian Hondorp, et al.
Anticancer Research|January 25, 2023
Clear-cell Variant of Mucoepidermoid Carcinoma Presenting as a Palatal Mass in a 10-Year-old BoySophia H Han, Thomas R O'Toole, Reid G Meyer, et al.
Cancer Treatment Reports|February 1, 1979
Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group studyD S Alberts, T E Moon, R A Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group StudyL R Laufman, J B Green, D S Alberts, et al.
American Journal of Clinical Oncology|February 1, 1994
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group studyV K Malviya, P Y Liu, R O'Toole, et al.
British Journal of Pharmacology|October 20, 2010
Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liverM Dogra, B D Palmer, G Bashiri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancerD S Alberts, S Green, E V Hannigan, et al.
Cancer|January 15, 1993
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group studyD S Alberts, S Dahlberg, S J Green, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Bacteriology|July 10, 1999
The chemotactic response of Vibrio anguillarum to fish intestinal mucus is mediated by a combination of multiple mucus componentsR O'Toole, S Lundberg, S A Fredriksson, et al.
Obstetrics and Gynecology|April 1, 1990
Carboplatin therapy in advanced endometrial cancerJ B Green, S Green, D S Alberts, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 15, 2017
Prevention of Tracheostomy-Related Hospital-Acquired Pressure UlcersThomas R O'Toole, Natalie Jacobs, Brian Hondorp, et al.
Anticancer Research|January 25, 2023
Clear-cell Variant of Mucoepidermoid Carcinoma Presenting as a Palatal Mass in a 10-Year-old BoySophia H Han, Thomas R O'Toole, Reid G Meyer, et al.
Cancer Treatment Reports|February 1, 1979
Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group studyD S Alberts, T E Moon, R A Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group StudyL R Laufman, J B Green, D S Alberts, et al.
American Journal of Clinical Oncology|February 1, 1994
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group studyV K Malviya, P Y Liu, R O'Toole, et al.
British Journal of Pharmacology|October 20, 2010
Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liverM Dogra, B D Palmer, G Bashiri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancerD S Alberts, S Green, E V Hannigan, et al.
Cancer|January 15, 1993
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group studyD S Alberts, S Dahlberg, S J Green, et al.
Pageof 5